Group 1 - The core viewpoint of the article highlights the upcoming IPO of Aisheren, which is set to issue shares at a price of 15.98 yuan, with a total market value of 811 million yuan and a price-to-earnings ratio of 14.99 [2][3] - Aisheren is the largest manufacturer of medical care pads in China, with its main products accounting for 53.41% in rehabilitation care products and 45.76% in surgical infection control products [2][3] - The company has over 20 years of industry experience and has established partnerships with international groups such as Medline, which enhances its future business development prospects [2][3] Group 2 - The company reported a net profit of 691.64 million yuan for the past three years, with a projected growth of 20.36% for 2024 [3] - Revenue figures for the last three years include 574.66 million yuan in 2023 (up 0.19%) and 573.56 million yuan in 2022 [3] - The funds raised from the IPO will be directed towards the construction of the Caple Public Health Medical Supplies Industrial Park [3]
【1月12日IPO雷达】爱舍伦申购
Xuan Gu Bao·2026-01-12 15:39